Therefore, targeting TAMs can be a promising therapy for cancer.[71] High‐mobility group box 1(HMGB1) from HCC increases the production of ROS depending on NOX2, which is capable of trigging autophagy through TLR2. This evidence concerns the gene HMGB1 and hepatocellular carcinoma.